Clinical Trial Results

February 23, 2016

A+ A-

Email Print

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies
Source: Clinical Trial Results Published on 2019-10-22
OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Source: Clinical Trial Results Published on 2019-10-22
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma
Source: Clinical Trial Results Published on 2019-10-21
[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients with HER2-positive Metastatic Breast Cancer
Source: Clinical Trial Results Published on 2019-10-17
Lilly Announces Phase 3 Study of Pegilodecakin in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival
Source: Clinical Trial Results Published on 2019-10-16
Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis
Source: Clinical Trial Results Published on 2019-10-12
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
Source: Clinical Trial Results Published on 2019-10-10
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy AKCEA-ANGPTL3-LRx
Source: Clinical Trial Results Published on 2019-10-07
Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection
Source: Clinical Trial Results Published on 2019-10-07
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
Source: Clinical Trial Results Published on 2019-10-04
Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer’s Patients
Source: Clinical Trial Results Published on 2019-10-02
AstraZeneca Announces FDA Complete Response Letter Regarding NDA for PT010 in COPD
Source: Clinical Trial Results Published on 2019-10-01
CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH
Source: Clinical Trial Results Published on 2019-10-01
Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis
Source: Clinical Trial Results Published on 2019-10-01
Novartis Announces Positive Results from Phase III PALLADIUM Study of Inhaled Combination QMF149 in Patients with Uncontrolled Asthma
Source: Clinical Trial Results Published on 2019-09-30

Scroll